Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Minoxidil and finasteride effectively treat hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Some alternative treatments for hair loss might work, but more research is needed.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.